New Pivotal Studies in Glaucoma

New Drop Data. The 2015 UKGTS is a randomized, triple-masked, placebo-controlled trial in which patients with newly diagnosed open-angle ...

Exploring The Latest Breakthroughs In Glaucoma Research

Genetic research has provided valuable insights into the hereditary factors contributing to glaucoma. Scientists have identified several genes ...

Emerging glaucoma treatments: are we seeing an improvement in ...

New trials have demonstrated the importance of behavioral support alongside medical and surgical treatment to optimally engage patients in their glaucoma care.

Pivotal studies in glaucoma in the past 10 years | Die Ophthalmologie

The Ocular Hypertension Treatment Study (OHTS) determined risk factors for glaucoma and also provided the first evidence that lowering ...

Glaukos Announces Positive Topline Outcomes in Phase 3 ...

The multi-center, randomized, placebo and sham controlled Phase 3 confirmatory pivotal trial randomized 312 eyes and was designed to evaluate ...

A Review of the Most Impactful Glaucoma Studies - Modern Optometry

The Advanced Glaucoma Intervention Study (AGIS) was a 10-year multi-part study that found that patients who had initial trabeculectomy showed a greater decrease ...

Clinical Trials in Glaucoma - EyeWiki

A succint review of landmark clinical trials in the treatment of glaucoma and ocular hypertension ... new disk hemorrhage. The clinical course ( ...

New Devices in Glaucoma - PMC - PubMed Central

In a 2-year prospective randomized clinical trial, PreserFlo was inferior to trabeculectomy at reducing IOP but had reduced risk for hypotony [9] ...

Nicox publishes results of Phase 3 trial of NCX 470 for treatment of ...

Nicox SA announced results from the Mont Blanc pivotal Phase 3 trial comparing NCX 470 to latanoprost in the lowering of intraocular ...

Glaucoma Clinical Research: Trends in Treatment Strategies and ...

Several PGAs have been evaluated in clinical trials over the past decades to find new PGAs with improved tolerability and therapeutic benefits. Omidenepag ...

Visual Field Outcomes of Two Major Glaucoma Trials

The trial found a sustained, significant reduction in the need for secondary glaucoma surgery and medication use in the CSH patients.8. STUDY IN BRIEF. A post ...

New research aims to develop novel therapeutic for glaucoma

INDIANAPOLIS—Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma ...

Glaukos Announces Positive Topline Outcomes for Both Phase 3 ...

Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating ...

ODs apply results of pivotal studies to their glaucoma practices

... the implications of these studies come to be fully understood, optometrists are beginning to incorporate this new knowledge into their practices. “These

Using pivotal study data to guide glaucoma patient management ...

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression.

Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial

The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be clinically and cost-effective as a primary ...

Landmark Glaucoma Studies: Key Findings and Treatment Lessons

A pioneer among glaucoma trials, OHTS was the first to demonstrate clearly that treating abnormally elevated intraocular pressure (IOP) with ...

Clinical Data on iStent Surgery | Glaucoma - Glaukos Corporation

In the US IDE Trial (n=505 subjects), iStent inject® met all study endpoints and demonstrated a clinically significant reduction in IOP for iStent inject® ...

Clinical Trials | Ophthalmology - Stanford Medicine

Background: The study is focused on finding new ways to detect and monitor glaucoma and its treatments. ... pivotal studies. Status: Active. PI: Andrea L Kossler, ...

New Devices in Glaucoma | Ophthalmology and Therapy

A meta-analysis showed that it can reduce IOP by 35% to a final mean value of 15 mmHg [2]. In a recent randomized contolled trial of 158 eyes, ...